Use of the anti-secretory factor (AF) in Glioblastoma disposal

Title:

Use of the anti-secretory factor (AF) in Glioblastoma disposal

Document Type and Number:

Japanese Patent JP6204490

Kind Code:

B2

Abstract:

The present invention relates to the use of an antisecretory factor (AF) protein, peptide, derivative, homologue, and/or fragment thereof, having equivalent functional activity, and/or a pharmaceutically active salt thereof, for treating glioblastoma. In one embodiment, AF proteins are used for optimizing delivery and cellular uptake of a pharmaceutical substance and/or formulation, or a gene delivery. Typically, said pharmaceutical substance and/or formulation comprises an anticancer drug, radiation therapy, an antibiotic substance, an immunoactive compound or a drug targeting posttraumatic injury, neurodegeneration, or an inflammatory condition.

More Like This:

WO/2023/173094	LYSINE-FREE UBIQUIBODY VARIANTS FOR LONG-LIVED INTRACELLULAR PROTEIN SILENCING
WO/2018/213710	METHODS OF TREATMENT FOR CERVICAL DYSTONIA
JPS56100720	FRACTIONATION OF MOLTEN SALTTCONTAINING LIQUID PROTEIN MIXTURE AND DEVICE THEREFOR

Inventors:

Hans-Arne Hanson

Application Number:

JP2015548644A

Publication Date:

September 27, 2017

Filing Date:

December 20, 2013

Export Citation:

Click for automatic bibliography generation Help

Assignee:

Landmenen Aes-Factor Arbe

International Classes:

A61K38/16; A23L33/18; A61K31/4188; A61K35/54; A61K38/08; A61P25/00; A61P35/00; C07K7/06; C07K14/47

Domestic Patent References:

JP2012517467A
JP2007506735A
JP2011529467A
JP2008540429A
JP2002533106A

Foreign References:

WO2012075414A1

Attorney, Agent or Firm:

Junji Yuda
Noriyuki Takebayashi

Previous Patent: An engine supercharger

Next Patent: Verification of the dishonest act in an self-checkout terminal